Contemporary Use and Clinical Significance of Initial Triple Versus Double Therapy After Percutaneous Coronary Intervention for Myocardial Infarction in Patients With Atrial Fibrillation
Immediate double therapy post-PCI is frequently used and appears safe for most patients with atrial fibrillation. Further studies are needed to identify high-risk subgroups, including those with ST-segment-elevation myocardial infarction, who may benefit from an initial short course of triple therapy.
Authors
- Darrick K. Li (ORCID: https://orcid.org/0000-0002-1983-0165)
- Zafer Akman (ORCID: https://orcid.org/0000-0002-6317-4417)
- Michael G. Nanna (ORCID: https://orcid.org/0000-0001-5745-1636)
- Dae Yong Park (ORCID: https://orcid.org/0000-0002-1486-7452)
- Bianca McLean (ORCID: https://orcid.org/0000-0001-9141-525X)
- Golsa Babapour (ORCID: https://orcid.org/0009-0009-5018-3099)
Institutions
- Yale University (US)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-05-22
- DOI
- https://doi.org/10.1161/jaha.124.038589
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00